{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:04:45Z","timestamp":1791443085993,"version":"4.3.3"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bcp.2023.115858","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T03:40:06Z","timestamp":1697600406000},"page":"115858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Potential role of soluble CD40 receptor in chronic inflammatory diseases"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2723-5953","authenticated-orcid":false,"given":"A.H.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Klersy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2023.115858_b0005","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/j.1460-2075.1989.tb03521.x","article-title":"A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas","volume":"8","author":"Stamenkovic","year":"1989","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"20","key":"10.1016\/j.bcp.2023.115858_b0015","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1074\/jbc.274.20.14246","article-title":"CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding Site Specificity and Activation of Downstream Pathways by Distinct TRAFs","volume":"274","author":"Pullen","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2023.115858_b0020","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0969-2126(01)00239-8","article-title":"2 A crystal structure of an extracellular fragment of human CD40 ligand","volume":"3","author":"Karpusas","year":"1995","journal-title":"Structure"},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0025","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/eji.1830261246","article-title":"Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells","volume":"26","author":"Ludewig","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0030","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/eji.1830250639","article-title":"A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation","volume":"25","author":"Graf","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0035","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.106.683201","article-title":"CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1","volume":"115","author":"Zirlik","year":"2007","journal-title":"Circulation"},{"issue":"6826","key":"10.1016\/j.bcp.2023.115858_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/35066602","article-title":"Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA","volume":"410","author":"Siddiqa","year":"2001","journal-title":"Nature"},{"issue":"6373","key":"10.1016\/j.bcp.2023.115858_b0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/357080a0","article-title":"Molecular and biological characterization of a murine ligand for CD40","volume":"357","author":"Armitage","year":"1992","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0167-5699(93)90188-Q","article-title":"CD40 ligand and its role in X-linked hyper-IgM syndrome","volume":"14","author":"Callard","year":"1993","journal-title":"Immunol. Today"},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcm.2007.02.004","article-title":"CD40 and its ligand in atherosclerosis","volume":"17","author":"Lutgens","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2023.115858_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115298","article-title":"Role of CD40 ligand-mediated endothelial cell-monocyte interaction at atherosclerosis predilection sites","volume":"206","author":"Lont","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115858_b0065","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fgene.2020.00542","article-title":"Identification of four potential biomarkers associated with coronary artery disease in non-diabetic patients by gene co-expression network analysis","volume":"11","author":"Jiao","year":"2020","journal-title":"Front. Genet."},{"issue":"10","key":"10.1016\/j.bcp.2023.115858_b0070","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1073\/pnas.92.10.4342","article-title":"CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression","volume":"92","author":"Karmann","year":"1995","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0075","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1073\/pnas.98.4.1751","article-title":"Regulation of CD40 function by its isoforms generated through alternative splicing","volume":"98","author":"Tone","year":"2001","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.molimm.2008.08.280","article-title":"Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing","volume":"46","author":"Eshel","year":"2008","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0085","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/cvr\/cvz206","article-title":"Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease","volume":"116","author":"Sultan","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.bcp.2023.115858_b0090","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/ATVBAHA.107.145961","article-title":"Cholesterol-dependent and -independent CD40 internalization and signaling activation in cardiovascular endothelial cells","volume":"27","author":"Chen","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2023.115858_b0095","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2010-11-320259","article-title":"Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signaling in human endothelial cells","volume":"118","author":"Wagner","year":"2011","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bcp.2023.115858_b0100","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.107.730309","article-title":"Cyclic stretch controls the expression of CD40 in endothelial cells by changing their transforming growth factor-beta1 response","volume":"116","author":"Korff","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9149(00)01266-2","article-title":"Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions","volume":"87","author":"Bruemmer","year":"2001","journal-title":"Am. J. Cardiol."},{"issue":"35","key":"10.1016\/j.bcp.2023.115858_b0110","doi-asserted-by":"crossref","first-page":"32801","DOI":"10.1074\/jbc.M209993200","article-title":"Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling","volume":"278","author":"Contin","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1097-0320(19970215)30:1<33::AID-CYTO5>3.0.CO;2-G","article-title":"High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants","volume":"30","author":"De Paoli","year":"1997","journal-title":"Cytometry"},{"key":"10.1016\/j.bcp.2023.115858_b0120","doi-asserted-by":"crossref","unstructured":"F. Zunke, S. Rose-John, The shedding protease ADAM17: Physiology and pathophysiology, Biochim Biophys Acta Mol Cell Res 1864(11 Pt B) (2017) 2059-2070.","DOI":"10.1016\/j.bbamcr.2017.07.001"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2023.115858_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12859-017-1465-7","article-title":"SheddomeDB: the ectodomain shedding database for membrane-bound shed markers","volume":"18","author":"Tien","year":"2017","journal-title":"BMC Bioinf."},{"issue":"7571","key":"10.1016\/j.bcp.2023.115858_b0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/nrg.2015.12","article-title":"Disease genetics: SNP location helps predict disease aetiology","volume":"17","author":"Lieben","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"Database issue","key":"10.1016\/j.bcp.2023.115858_b0140","doi-asserted-by":"crossref","first-page":"D1308","DOI":"10.1093\/nar\/gkr798","article-title":"SNPedia: a wiki supporting personal genome annotation, interpretation and analysis","volume":"40","author":"Cariaso","year":"2012","journal-title":"Nucl. Acids Res."},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0145","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/105072502321085234","article-title":"A C\/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease","volume":"12","author":"Tomer","year":"2002","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","article-title":"Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes","volume":"44","author":"Kozak","year":"1986","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0155","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","article-title":"A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology","volume":"146","author":"Jacobson","year":"2005","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.bcp.2023.115858_b0160","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1182\/blood-2007-09-112144","article-title":"A functional TNFRSF5 gene variant is associated with risk of lymphoma","volume":"111","author":"Skibola","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0165","doi-asserted-by":"crossref","first-page":"e0127080","DOI":"10.1371\/journal.pone.0127080","article-title":"The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function","volume":"10","author":"Field","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2023.115858_b0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopha.2009.09.021","article-title":"A common polymorphism in CD40 Kozak sequence (-1C\/T) is associated with acute coronary syndrome","volume":"64","author":"Tian","year":"2010","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10238-010-0092-7","article-title":"Association analysis of CD40 gene polymorphism with acute coronary syndrome","volume":"10","author":"Yan","year":"2010","journal-title":"Clin. Exp. Med."},{"issue":"60","key":"10.1016\/j.bcp.2023.115858_b0180","doi-asserted-by":"crossref","first-page":"102235","DOI":"10.18632\/oncotarget.18704","article-title":"Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis","volume":"8","author":"Qin","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bcp.2023.115858_b0185","doi-asserted-by":"crossref","first-page":"e23762","DOI":"10.1371\/journal.pone.0023762","article-title":"Association of CD40 gene polymorphisms with sporadic breast cancer in Chinese Han women of Northeast China","volume":"6","author":"Shuang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115858_b0190","first-page":"7497314","article-title":"The CD40 rs1883832 Polymorphism Affects Sepsis Susceptibility and sCD40L Levels","volume":"2018","author":"Liu","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"7","key":"10.1016\/j.bcp.2023.115858_b0195","doi-asserted-by":"crossref","first-page":"e11520","DOI":"10.1371\/journal.pone.0011520","article-title":"CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility","volume":"5","author":"Blanco-Kelly","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bcp.2023.115858_b0200","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/hmg\/ddac284","article-title":"A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2\/CD40\/BST2 axis","volume":"32","author":"Chen","year":"2023","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bcp.2023.115858_b0205","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.21816","article-title":"Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies","volume":"106","author":"Hock","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13046-018-0851-y","article-title":"ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis","volume":"37","author":"Ma","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prp.2010.09.007","article-title":"Annexin A2 as a differential diagnostic marker of hepatocellular tumors","volume":"207","author":"Longerich","year":"2011","journal-title":"Pathol. Res. Pract."},{"issue":"10","key":"10.1016\/j.bcp.2023.115858_b0220","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of rheumatoid arthritis","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2023.115858_b0225","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/ard.2009.109579","article-title":"Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study","volume":"69","author":"Orozco","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0230","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/art.24245","article-title":"Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations","volume":"60","author":"Lee","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0235","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ncprheum0592","article-title":"Mechanisms of disease: genetics of rheumatoid arthritis\u2013ethnic differences in disease-associated genes","volume":"3","author":"Yamada","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115858_b0240","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/art.24721","article-title":"Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis","volume":"60","author":"van der Linden","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/gepi.22168","article-title":"ComPaSS-GWAS: A method to reduce type I error in genome-wide association studies when replication data are not available","volume":"43","author":"Sabourin","year":"2019","journal-title":"Genet. Epidemiol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0250","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.bbamcr.2017.05.024","article-title":"Molecular insights into the multilayered regulation of ADAM17: The role of the extracellular region","volume":"1864","author":"Gr\u00f6tzinger","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Molec. Cell Res."},{"issue":"15","key":"10.1016\/j.bcp.2023.115858_b0255","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/cells12151926","article-title":"Ectodomain shedding by ADAM17 increases the release of soluble CD40 from human endothelial cells under pro-inflammatory conditions","volume":"12","author":"Klersy","year":"2023","journal-title":"Cells"},{"issue":"34","key":"10.1016\/j.bcp.2023.115858_b0260","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/bi500409n","article-title":"Identification of cleavage sites leading to the shed form of the anti-aging protein klotho","volume":"53","author":"Chen","year":"2014","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0265","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/pr401135u","article-title":"LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries","volume":"13","author":"Tucher","year":"2014","journal-title":"J. Proteome Res."},{"issue":"39","key":"10.1016\/j.bcp.2023.115858_b0270","doi-asserted-by":"crossref","first-page":"37459","DOI":"10.1074\/jbc.M305877200","article-title":"Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17)","volume":"278","author":"Garton","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0275","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1074\/jbc.M510797200","article-title":"Tumor necrosis factor-alpha-converting enzyme (TACE\/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1)","volume":"281","author":"Tsakadze","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/ATVBAHA.116.308682","article-title":"Adam17 deficiency promotes atherosclerosis by enhanced TNFR2 signaling in mice","volume":"37","author":"Nicolaou","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0285","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2014.05.946","article-title":"Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice","volume":"235","author":"St\u00f6hr","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0290","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI114663","article-title":"Increased endothelial albumin permeability mediated by protein kinase C activation","volume":"85","author":"Lynch","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0295","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1046\/j.1432-1033.2003.03606.x","article-title":"Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation","volume":"270","author":"Endres","year":"2003","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0300","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molcel.2010.01.034","article-title":"Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation","volume":"37","author":"Xu","year":"2010","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bcp.2023.115858_b0305","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1074\/jbc.M113.536847","article-title":"Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor \u03b1 ectodomain shedding","volume":"289","author":"Schwarz","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0310","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/JLB.3VMR0219-069R","article-title":"Novel functions of inactive rhomboid proteins in immunity and disease","volume":"106","author":"Geesala","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0315","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.bbamcr.2017.04.016","article-title":"Rhomboid proteases in human disease: mechanisms and future prospects","volume":"1864","author":"D\u00fcsterh\u00f6ft","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Molec. Cell Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115858_b0320","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.celrep.2017.09.074","article-title":"Phosphorylation of iRhom2 controls stimulated proteolytic shedding by the metalloprotease ADAM17\/TACE","volume":"21","author":"Cavadas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2023.115858_b0325","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35032","article-title":"iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom\/TACE","volume":"7","author":"Oikonomidi","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2023.115858_b0330","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23968","article-title":"Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling","volume":"6","author":"Grieve","year":"2017","journal-title":"Elife"},{"issue":"24","key":"10.1016\/j.bcp.2023.115858_b0335","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1182\/blood-2012-03-417949","article-title":"iRhom2 is required for the secretion of mouse TNF\u03b1","volume":"119","author":"Siggs","year":"2012","journal-title":"Blood"},{"issue":"6065","key":"10.1016\/j.bcp.2023.115858_b0340","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1214448","article-title":"iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS","volume":"335","author":"McIlwain","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0345","doi-asserted-by":"crossref","first-page":"24230","DOI":"10.1038\/s41598-021-03522-2","article-title":"Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells","volume":"11","author":"Giese","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115858_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.887830","article-title":"Attenuation of excess TNF-\u03b1 release in crohn's disease by silencing of iRHOMs 1\/2 and the restoration of TGF-\u03b2 mediated immunosuppression through modulation of TACE trafficking","volume":"13","author":"Louis","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0355","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/eji.1830240402","article-title":"B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40","volume":"24","author":"van Kooten","year":"1994","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0360","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/cvr\/cvz286","article-title":"rs1883832: a CD40 single-nucleotide polymorphism for predicting coronary heart disease in humans","volume":"116","author":"Lutgens","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12265-020-09994-3","article-title":"The CD40-CD40L dyad as immunotherapeutic target in cardiovascular disease","volume":"14","author":"Bosmans","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"6","key":"10.1016\/j.bcp.2023.115858_b0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00380-005-0840-x","article-title":"Inverse correlation between soluble CD40 ligand and soluble CD40 is absent in patients with unstable angina","volume":"20","author":"Tsuzuki","year":"2005","journal-title":"Heart Vessels"},{"issue":"8","key":"10.1016\/j.bcp.2023.115858_b0375","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1440-1681.2010.05394.x","article-title":"Association between serum levels of soluble CD40\/CD40 ligand and organ damage in hypertensive patients","volume":"37","author":"Yuan","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115858_b0385","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5853\/jos.2021.00178","article-title":"Soluble CD40 levels in plasma are associated with cardiovascular disease and in carotid plaques with a vulnerable phenotype","volume":"23","author":"Shami","year":"2021","journal-title":"J Stroke"},{"issue":"10","key":"10.1016\/j.bcp.2023.115858_b0390","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2337\/dc18-0185","article-title":"Use of vascular assessments and novel biomarkers to predict cardiovascular events in type 2 diabetes: the SUMMIT VIP study","volume":"41","author":"Shore","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2023.115858_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.01.003","article-title":"Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk","volume":"343","author":"Leonetti","year":"2022","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.bcp.2023.115858_b0400","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0405","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.4049\/jimmunol.1601988","article-title":"CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progression","volume":"198","author":"Guo","year":"2017","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115858_b0410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10238-019-00568-5","article-title":"Assessment of CD40 and CD40L expression in rheumatoid arthritis patients, association with clinical features and DAS28","volume":"19","author":"Rom\u00e1n-Fern\u00e1ndez","year":"2019","journal-title":"Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0415","first-page":"353","article-title":"Increased serum soluble CD40 levels in patients with systemic sclerosis","volume":"34","author":"Komura","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2023.115858_b0420","unstructured":"R. Adigun, A. Goyal, A. Hariz, Systemic sclerosis, 2017."},{"key":"10.1016\/j.bcp.2023.115858_b0425","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","article-title":"Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond","volume":"141","author":"Karnell","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2023.115858_b0430","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12863-015-0279-8","article-title":"The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus","volume":"16","author":"Chen","year":"2015","journal-title":"BMC Genet."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00296-015-3345-7","article-title":"Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0440","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1002\/mgg3.1014","article-title":"Association of soluble CD40 levels with -1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus","volume":"7","author":"Tapia-Llanos","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115858_b0445","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10067-018-4349-y","article-title":"The association of CD40 polymorphism (rs1883832C\/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients","volume":"38","author":"Mousa","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115858_b0450","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-019-04491-8","article-title":"Letter to the editor: \u201cThe association of CD40 polymorphism (rs1883832C\/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients\u201d","volume":"38","author":"Rom\u00e1n-Fern\u00e1ndez","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0455","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0961203319878822","article-title":"Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis","volume":"28","author":"Bae","year":"2019","journal-title":"Lupus"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2023.115858_b0460","first-page":"i20","article-title":"Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane","volume":"3","author":"Contin-Bordes","year":"2010","journal-title":"NDT Plus"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0465","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2249.1999.00935.x","article-title":"Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients","volume":"117","author":"Schwabe","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0470","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1038\/s41598-017-08426-8","article-title":"Circulating CD40 and sCD40L predict changes in renal function in subjects with chronic kidney disease","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2023.115858_b0475","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.3390\/jcm9113653","article-title":"CD40\/CD40L signaling as a promising therapeutic target for the treatment of renal disease","volume":"9","author":"Zhang","year":"2020","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.bcp.2023.115858_b0480","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3390\/ijms23084115","article-title":"CD40-CD40L in Neurological Disease","volume":"23","author":"Ots","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0485","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/187152710791012099","article-title":"Impact of the CD40-CD40L dyad in Alzheimer's disease","volume":"9","author":"Giunta","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0490","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2008.10.091","article-title":"Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease","volume":"450","author":"Buchhave","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0495","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cyto.2008.08.013","article-title":"Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease","volume":"44","author":"Ait-ghezala","year":"2008","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.bcp.2023.115858_b0500","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bcp.2023.115858_b0505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neulet.2018.11.019","article-title":"Association of CSF CD40 levels and synaptic degeneration across the Alzheimer's disease spectrum","volume":"694","author":"Ye","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0510","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/diagnostics11122339","article-title":"Neurogranin as a reliable biomarker for synaptic dysfunction in Alzheimer's disease","volume":"11","author":"Agnello","year":"2021","journal-title":"Diagnostics (basel)"},{"issue":"1","key":"10.1016\/j.bcp.2023.115858_b0515","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","article-title":"Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies","volume":"26","author":"Zetterberg","year":"2021","journal-title":"Mol. Psych."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0520","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41416-021-01377-y","article-title":"The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer","volume":"125","author":"Meltzer","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2023.115858_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107709","article-title":"Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint","volume":"219","author":"Tang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2023.115858_b0530","first-page":"49","article-title":"Significance of soluble CD40 and CD40 ligand levels in childhood acute lymphoblastic leukemia patients","author":"G\u00f6k","year":"2022","journal-title":"J. Transl. Pract. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115858_b0535","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3892\/etm.2015.2182","article-title":"Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B","volume":"9","author":"Shen","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0540","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/B:APPT.0000018802.95600.25","article-title":"Role of circulating soluble CD40 as an apoptotic marker in liver disease","volume":"9","author":"Schmilovitz-Weiss","year":"2004","journal-title":"Apoptosis"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2023.115858_b0545","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clinbiochem.2010.11.003","article-title":"CD40\/SCD40 imbalance in hemodialysis patients","volume":"44","author":"Esposito","year":"2011","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.bcp.2023.115858_b0550","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bcp.2023.115858_b0555","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/01.ATV.17.3.505","article-title":"Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin","volume":"17","author":"Peter","year":"1997","journal-title":"Arter Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115858_b0560","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.atherosclerosis.2015.01.029","article-title":"A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis","volume":"239","author":"Rizza","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:37:10Z","timestamp":1736329030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":112,"alternative-id":["S0006295223004495"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115858","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential role of soluble CD40 receptor in chronic inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115858"}}